Anabtawi, I. N., Ellison, R. G., and Ellison, L. T. 1965. Pulmonary arteriovenous aneurysms and fistulas. Anatomical variations, embryology, and classification. Ann Thorac Surg, 122, 277–85.Google Scholar

Barth, K. H., White, R. I., Kaufman, S. L., et al. 1982. Embolotherapy pulmonary arteriovenous malformations with detachable balloons. Radiology, 142, 599–606.CrossRefGoogle ScholarPubMed

Barzilai, B., Waggoner, A. D., Spessert, C., Picus, E., and Goodenberger, D. 1999. Two-dimensional contrast echocardiography in the detection and followup of congenital pulmonary arteriovenous malformations. Am J Cardiol, 68, 1507–10.Google Scholar

Beck, A., Dagan, T., Matitiau, A., et al. 2006. Transcatheter closure of pulmonary arteriovenous malformation with Amplatzer devices. Catheter Cardiovasc Interv, 67, 932–7.Google ScholarPubMed

Berg, J. N., Guttmacher, A. E., Marchuk, D. A., et al. 1996. Clinical heterogeneity in hereditary haemorrhagic telangiectasia: Are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet, 33, 256–7.CrossRefGoogle ScholarPubMed

Babaker, M., Breault, S., Beigelman, C., et al. 2015. Endovascular treatment of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Swiss Med Wkly, 145: w14151.10.4414/smw.2015.14151CrossRefGoogle ScholarPubMed

Blanco, P., Schaeverbeke, T., Baillet, L., et al. 1998. Rendu–Osler familial telangiectasia angiomatosis and bacterial spondylodiscitis [in French]. Rev Med Interne, 19, 938–9.10.1016/S0248-8663(99)80070-8CrossRefGoogle ScholarPubMed

Bosher, L. H., Blake, D. A., and Byrd, B. R. 1959. Analysis of the pathologic anatomy of pulmonary arteriovenous aneurysms with particular reference to the applicability of local excision. Surgery, 45, 91–104.Google Scholar

Bossler, A. D., Richards, J., George, C., et al., 2006. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): Correlation of genotype with phenotype. Hum Mutat, 27, 667–75.CrossRefGoogle Scholar

Churton, T. 1897. Multiple aneurysms of the pulmonary artery. Br Med J, 1, 1223–5.Google Scholar

Cil, B., Canyigit, M., Ozkan, O. S., et al. 2006. Bilateral multiple pulmonary arteriovenous malformations: Endovascular treatment with the Amplatzer vascular plug. J Vasc Interv Radiol, 17, 141–5.Google ScholarPubMed

Cohen, R., Cabanes, L., Burckel, C., et al. 2006. Pulmonary arteriovenous fistulae recurrent stroke. J Neurol Neurosurg Psychiatry, 77, 707–8.10.1136/jnnp.2005.079764CrossRefGoogle ScholarPubMed

Coley, S. C. and Jackson, J. E. 1998. Endovascular occlusion with a new mechanical detachable coil. AJR Am J Roentgenol, 171, 1075–9.CrossRefGoogle ScholarPubMed

Cottin, V., Chinet, T., Lavole, A., et al. 2007. Pulmonary arteriovenous malformations in hemorrhagic hereditary telangiectasia: A series of 126 patients. Medicine (Baltimore), 86, 1–17.10.1097/MD.0b013e31802f8da1CrossRefGoogle ScholarPubMed

Cottin, V., Plauchu, H., Bayle, J. Y., et al. 2004. Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med, 169, 994.CrossRefGoogle ScholarPubMed

David, C., Brasme, L., Peruzzi, P., et al. 1997. Intramedullary abscess of the spinal cord in a patient with a right-to-left shunt: Case report. Clin Infect Dis, 24, 89–90.CrossRefGoogle Scholar

Del Sette, M., Angeli, S., Leandri, M., et al. 1998. Migraine with aura and right-to-left shunt on transcranial Doppler: A case–control study. Cerebrovasc Dis, 8, 327–30.CrossRefGoogle ScholarPubMed

Desproges-Gotteron, R., Francon, F., and Diaz, R. 1973. Un cas d’arthrite purulente au cours d’une angiomatose de Rendu–Osler (telangiectasia hereditaria hemorrhagica). Vie Méd Can F, 2, 223–5.Google Scholar

Devuyst, G. 1999. New trends in neurosonology. In Fisher, M. and Bogousslavsky, J., eds., Current Review of Cerebrovascular Disease. Philadelphia: Current Medicine, Inc., pp. 65–76.Google Scholar

Dines, D. E., Arms, R. A., Bernatz, P. E., et al. 1974. Pulmonary arteriovenous fistulas. Mayo Clin Proc, 49, 460–5.Google ScholarPubMed

Dines, D. E., Seward, J. B., Bernatz, P. E., et al. 1983. Pulmonary arteriovenous fistulas. Mayo Clin Proc, 58, 176–81.Google ScholarPubMed

Dinkel, H. P. and Triller, J. 2002. Pulmonary arteriovenous malformations: Embolotherapy with the superselective coaxial catheter placement and filling of venous sac with Guglielmi detachable coils. Radiology, 223, 709–14.10.1148/radiol.2233010953CrossRefGoogle ScholarPubMed

Donaldson, J. W., McKeever, T. M., Hall, I. P., Hubbard, R. B., and Fogarty, A. W. 2015. Complications and mortality in hereditary hemorrhagic telangiectasia: A population-based study. Neurology, 84, 1886–93.10.1212/WNL.0000000000001538CrossRefGoogle ScholarPubMed

Dutton, J. A. E., Jackson, J. E., Hughes, J. M. B., et al. 1995. Pulmonary arteriovenous malformations: Results of treatment with coil embolization in 53 patients. AJR Am J Roentgenol, 165, 1119–25.10.2214/ajr.165.5.7572487CrossRefGoogle ScholarPubMed

Edigo, R., Panades, M. J., Ramos, J., Guajardo, J., and Parra, R. 1991. Renal actinomycosis: presentation of a case. Acta Urol Esp, 15, 580–2.Google Scholar

Faughnan, M. E., Lui, Y. W., Wirth, J. A., et al. 2000. Diffuse pulmonary arteriovenous malformations: Characteristics and prognosis. Chest, 117, 31–8.10.1378/chest.117.1.31CrossRefGoogle ScholarPubMed

Faughnan, ME, Palda, VA, Garcia-Tsao, G., et al. 2011. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet, 48, 73–87.10.1136/jmg.2009.069013CrossRefGoogle ScholarPubMed

Gallione, C. J., Repetto, G. M., Legius, E., et al. 2004. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4(SMAD4). Lancet, 363, 852–9.10.1016/S0140-6736(04)15732-2CrossRefGoogle Scholar

Gallitelli, M., Guastamacchia, E., Resta, F., et al. 2006. Pulmonary arteriovenous malformations, hereditary haemorrhagic telangiectasia coma and brain abscess. Respiration, 73, 553–7.10.1159/000087150CrossRefGoogle Scholar

Gallitelli, M., Lepore, V., Pasculli, G., et al. 2005. Brain abscess: A need to screen for pulmonary arteriovenous malformations. Neuroepidemiology, 24, 76–8.10.1159/000081053CrossRefGoogle ScholarPubMed

Gossage, J. R. and Kanj, G. 1998. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med, 158, 643–61.10.1164/ajrccm.158.2.9711041CrossRefGoogle ScholarPubMed

Guttmacher, A. E., Marchuk, D. A., and White, R. I. Jr. 1995. Hereditary hemorrhagic telangiectasia. N Engl J Med, 333, 918–24.10.1056/NEJM199510053331407CrossRefGoogle ScholarPubMed

Gupta, P., Mordin, C., Curtis, J., et al., 2002. Pulmonary arteriovenous malformations: Effect of embolization on right-to-left shunt, hypoxemia, and exercise tolerance in 66 patients. AJR Am J Roentgenol, 179, 347–55.10.2214/ajr.179.2.1790347CrossRefGoogle ScholarPubMed

Harlan, N. P., Davies, L. H., Weaver, L. K., et al., 2015. Spontaneous cerebral gas embolism and pulmonary arteriovenous malformation: A case report. Undersea Hyperb Med, 42, 425–8.Google ScholarPubMed

Haitjema, T. J., Disch, F., Overtoom, T. T. C., et al. 1995a. Screening family members of patients with hereditary haemorrhagic telangiectasia. Am J Med, 99, 519–24.10.1016/S0002-9343(99)80229-0CrossRefGoogle Scholar

Haitjema, T. J., Overtoom, T. T. C., Westermann, C. J. J., et al. 1995b. Embolization of pulmonary arteriovenous malformation: Results and follow up in 32 patients. Thorax, 15, 719–23.Google Scholar

Hinterseer, M., Becker, A., Barth, A. S., et al. 2006. Interventional embolization of a giant pulmonary arteriovenous malformation with right–left-shunt associated with hereditary hemorrhagic telangiectasia. Clin Res Cardiol, 95, 174–8.10.1007/s00392-006-0345-3CrossRefGoogle ScholarPubMed

Hsu, Y. L., Wang, H. C., and Yang, P. C. 2004. Desbaric air embolism during diving: an unusual complication of Osler–Weber–Rendu disease. Br J Sports Med, 38, e6.10.1136/bjsm.2002.004432CrossRefGoogle ScholarPubMed

Hu, S. and Davis, C. 2009. Endovascular embolization with a vascular plug corrects a PAVM. JAAPA, 22, 27–8.10.1097/01720610-200910000-00006CrossRefGoogle ScholarPubMed

Jessurun, G. A., Kamphuis, D. J., van der Zande, E. H., et al. 1993. Cerebral arteriovenous malformations in the Netherlands Antilles: High prevalence of hereditary haemorrhagic telangiectasia-related single and multiple cerebral arteriovenous malformations. Clin Neurol Neurosurg, 95, 193–8.10.1016/0303-8467(93)90123-XCrossRefGoogle ScholarPubMed

Kim, H., Nelson, J., Krings, T., terBrugge, K. G. et al., 2015. Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia. Stroke, 46, 1362–4.Google ScholarPubMed

Kimura, K., Minematsu, K., Nakajima, M. 2004. Isolated primary arteriovenous fistula without Rendu–Osler–Weber disease as a cause of cryptogenic stroke. J Neurol Neurosurg Psychiatry, 75, 311–3.Google Scholar

Kucukay, F., Ozdemir, M., Senol, E. et al., 2014. Large pulmonary arteriovenous malformations: Long-term results of embolization with Amplatzer vascular plugs. J Vasc Interv Radiol, 25, 1327–32.CrossRefGoogle ScholarPubMed

Lee, D. W., White, R. I., Egglin, T. K., et al. 1997. Embolotherapy of large pulmonary arteriovenous malformations: Long-term results. Ann Thorac Surg, 64, 930–40.CrossRefGoogle ScholarPubMed

Lee, W. L., Graham, A. F., Pugash, R. A., et al. 2003. Contrast echocardiography remains positive after treatment of pulmonary arteriovenous malformations. Chest, 123, 351–8.10.1378/chest.123.2.351CrossRefGoogle ScholarPubMed

Lubarsky, M., Ray, C., and Funaki, B. 2010. Embolization agents: Which one should be used when? Part 2: Small-vessel embolization. Semin Intervent Radiol, 2010, 27, 99–104.10.1055/s-0030-1247891CrossRefGoogle ScholarPubMed

McDonald, J., Damjanovich, K., Millson, A., et al., 2011. Molecular diagnosis in hereditary hemorrhagic telangiectasia: Findings in a series tested simultaneously by sequencing and deletion/duplication analysis. Clin Genet, 79, 335–44.10.1111/j.1399-0004.2010.01596.xCrossRefGoogle Scholar

Mager, J. J., Overtoom, T. T., Mauser, H. W., et al. 2001. Early cerebral infarction after embolotherapy of pulmonary arteriovenous malformation. J Vasc Interv Radiol, 12, 122–3.10.1016/S1051-0443(07)61416-XCrossRefGoogle ScholarPubMed

Mager, J. J., Overtoom, T. T., Blauw, H., Lammers, J. W., and Westermann, C. J. 2004. Embolotherapy of pulmonary arteriovenous malformations: Long-term results in 112 patients. J Vasc Interv Radiol, 15, 451–6.10.1097/01.RVI.0000126811.05229.B6CrossRefGoogle ScholarPubMed

Maher, C. O., Piepgras, D. G., Brown, R. D., et al. 2001. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke, 32, 877–82.10.1161/01.STR.32.4.877CrossRefGoogle ScholarPubMed

Maniscalco, M., Zedda, A., Faraone, S., et al. 2005. Association of Adams–Oliver syndrome with pulmonary arterio-venous malformation in the same family. Am J Med Genet, 136, 269–74.Google ScholarPubMed

Marchuk, D. A. 1997. The molecular genetics of hereditary haemorrhagic telangiectasia. Chest, 111 (Suppl), 79s–82s.CrossRefGoogle Scholar

Moussouttas, M., Fayad, P., Rosenblatt, M., et al. 2000. Pulmonary arteriovenous malformations: Cerebral ischemia and neurologic manifestations. Neurology, 55, 959–64.10.1212/WNL.55.7.959CrossRefGoogle ScholarPubMed

Nanthakumar, K., Graham, A. T., Robinson, T. I., et al. 2001. Contrast echocardiography for detection of pulmonary arteriovenous malformations. Am Heart J, 141, 243–6.10.1067/mhj.2001.112682CrossRefGoogle ScholarPubMed

Ondra, S. L., Troupp, H., George, E. D., and Schwab, K. 1990. The natural history of symptomatic arteriovenous malformations of the brain: A 24-year follow-up assessment. J Neurosurg, 73, 387–91.10.3171/jns.1990.73.3.0387CrossRefGoogle ScholarPubMed

Parees, I., Horga, A., Santamarima, E., et al. 2010. Stroke after prolonged air travel associated with a pulmonary arteriovenous malformation. J Neurol Sci, 292, 99–100.10.1016/j.jns.2010.02.019CrossRefGoogle ScholarPubMed

Peters, B., Ewert, P., Schubert, S., et al. 2005. Rare case of pulmonary arteriovenous fistula simulating residual defect after transcatheter closure of patent foramen ovale for recurrent paradoxical embolism. Catheter Cardiovasc Interv, 64, 348–51.Google ScholarPubMed

Petrillo, T., Fortenberry, J., Chambliss, R., and Nall, K. 2001. Radiological case of the month. Arch Pediatr Adolesc Med, 155, 847–48.10.1001/archpedi.155.7.847CrossRefGoogle ScholarPubMed

Pierucci, P., Murphy, J., Henderson, K. J., et al. 2008. New definition and natural history of patients with diffuse pulmonary arteriovenous malformations: Twenty-seven-year experience. Chest, 133, 653–61.10.1378/chest.07-1949CrossRefGoogle ScholarPubMed

Plauchu, H., de Chadarevian, J. P., Bideau, A., et al. 1989. Age-related clinical profile of hereditary haemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet, 32, 291–7.10.1002/ajmg.1320320302CrossRefGoogle Scholar

Post, M. C., van Gent, M. W. F., Plokker, H. W. M., et al. 2009. Pulmonary arteriovenous malformations associated with migraine with aura. European Respiratory Journal, 34, 882–87.10.1183/09031936.00179008CrossRefGoogle ScholarPubMed

Post, M. C., Letteboer, T. G. W., Mager, J. J., et al. 2005. A pulmonary right to left shunt in patients with hereditary haemorrhagic telangiectasia is associated with an increased prevalence of migraine. Chest, 128, 2485–9.CrossRefGoogle ScholarPubMed

Post, M. C., Thijs, V., Herroelen, L., et al. 2004. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology, 62, 1439–40.10.1212/01.WNL.0000120756.25236.37CrossRefGoogle ScholarPubMed

Post, M. C., Thijs, V., Schonewille, W. J., et al. 2006. Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine. Neurology, 66, 202–5.10.1212/01.wnl.0000194257.75559.b0CrossRefGoogle ScholarPubMed

Prigoda, N. L., Savas, S., Abdalla, S.A., et al. 2006. Hereditary haemorrhagic telangiectasia: Mutation detection, test sensitivity and novel mutations. J Med Genet, 43, 722–8.CrossRefGoogle ScholarPubMed

Puskas, J. D., Allen, M. S., Moncure, A. C., et al. 1993. Pulmonary arteriovenous malformations: Therapeutic options. Ann Thorac Surg, 56, 253–8.10.1016/0003-4975(93)91156-HCrossRefGoogle ScholarPubMed

Remy, J., Remy-Jardin, M., Giraud, F., et al. 1994. Angioarchitecture of pulmonary arteriovenous malformations: Clinical utility of three-dimensional helical CT. Radiology, 191, 657–64.10.1148/radiology.191.3.8184042CrossRefGoogle ScholarPubMed

Retnakaran, R. R., Faughnan, M. E., Chan, R. P., et al. 2003. Pulmonary arteriovenous malformation: A rare, treatable cause of stroke in young adults. Int J Clin Pract, 57, 731–3.10.1111/j.1742-1241.2003.tb10598.xCrossRefGoogle ScholarPubMed

Richards-Yutz, J., Grant, K., Chao, E. C., et al. 2010. Update on molecular diagnosis of hereditary hemorrhagic telangiectasia. Hum Genet, 128, 61–77.10.1007/s00439-010-0825-4CrossRefGoogle ScholarPubMed

Roman, G., Fisher, M., Perl, D. P., et al. 1978. Neurological manifestations of hereditary haemorrhagic telangiectasia (Rendu–Osler–Weber disease): Report of 2 cases and review of the literature. Ann Neurol, 4, 130–44.10.1002/ana.410040207CrossRefGoogle ScholarPubMed

Saluja, S., Sitko, L., Lee, R. W., et al. 1999. Embolotherapy of pulmonary AVM with detachable balloons: Long-term durability and efficiency. J Vasc Interv Radiol, 10, 883–9.10.1016/S1051-0443(99)70132-6CrossRefGoogle Scholar

Sellon, E., Ring, A., Howlett, D. 2013 Ischaemic stroke secondary to paradoxical emboli through an arteriovenous malformation of the lung in a patient with known breast cancer. BMJ Case Rep, bcr2013008672.10.1136/bcr-2013-008672CrossRefGoogle Scholar

Schwerzmann, M., Wiher, S., Nedeltchev, K., et al. 2004. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology, 62, 1399–401.10.1212/01.WNL.0000120677.64217.A9CrossRefGoogle ScholarPubMed

Shovlin, C. L., Guttmacher, A. E., Buscarini, E., et al. 2000. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber syndrome). Am J Med Genet, 91, 66–7.10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P3.0.CO;2-P>CrossRefGoogle ScholarPubMed

Shovlin, C. L. and Letarte, M. 1999. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: Issues in clinical management and review of pathogenic mechanisms. Thorax, 54, 714–29.10.1136/thx.54.8.714CrossRefGoogle ScholarPubMed

Steele, J. G., Nath, P. U., Burn, J., et al. 1993. An association between migrainous aura and hereditary haemorrhagic telangiectasia. Headache, 33, 145–8.CrossRefGoogle ScholarPubMed

Swanson, K. L., Prakash, U. B., and Stanson, A. W. 1999. Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982–1997. Mayo Clin Proc, 74, 671–80.10.4065/74.7.671CrossRefGoogle Scholar

Tapping, C. R., Ettles, D. F., and Robinson, G. J. 2011. Long-term follow-up of treatment of pulmonary arteriovenous malformations with Amplatzer vascular plug and Amplatzer vascular plug II devices. J Vasc Interv Radiol, 22, 1740–46.10.1016/j.jvir.2011.08.029CrossRefGoogle ScholarPubMed

Thenganatt, J., Schneiderman, J., Hyland, R. H., et al. 2006. Migraines linked to intrapulmonary right-to-left shunt. Headache, 46, 439–43.10.1111/j.1526-4610.2006.00291.xCrossRefGoogle ScholarPubMed

Thompson, R. D., Jackson, J., Peters, A. M., et al. 1999. Sensitivity and specificity of radioisotope right–left shunt measurement and pulse oximetry for the early detection of pulmonary arteriovenous malformations. Chest, 115, 109–13.10.1378/chest.115.1.109CrossRefGoogle ScholarPubMed

Todo, K., Moriwaki, H., Higashi, M., et al. 2004. A small pulmonary arteriovenous malformation as a cause of recurrent brain embolism. AJNR Am J Neuroradiol, 25, 428–30.Google ScholarPubMed

Trerotola, S. O. and Pyeritz, R. E. 2010. PAVM embolization: An update. AJR Am J Roentgenol, 195, 837–45.10.2214/AJR.10.5230CrossRefGoogle ScholarPubMed

Trulock, E. P. 1997. Lung transplantation. Am J Respir Crit Care Med, 155, 789–818.10.1164/ajrccm.155.3.9117010CrossRefGoogle ScholarPubMed

Vase, P., Holm, M., and Arendrup, H. 1985. Pulmonary arteriovenous fistulas in hereditary haemorrhagic telangiectasia. Acta Med Scand, 218, 105–9.10.1111/j.0954-6820.1985.tb08832.xCrossRefGoogle Scholar

Watanabe, N., Munakata, Y., Ogiwara, M., et al. 1995. A case of pulmonary arteriovenous malformation in a patient with brain abscess successfully treated with video-assisted thoracoscopic resection. Chest, 108, 1724–7.10.1378/chest.108.6.1724CrossRefGoogle Scholar

Tsetsou, S., Eeckhout, E., Qanadli, S. D., et al., 2013. Nonaccidental arterial cerebral air embolism: A ten-year stroke center experience. Cerebrovasc Dis, 35, 392–5.CrossRefGoogle ScholarPubMed

White, R. I. Jr. 2007. Pulmonary arteriovenous malformations: How do I embolize? Tech Vasc Interv Radiol, 10, 283–90.10.1053/j.tvir.2008.03.007CrossRefGoogle ScholarPubMed

White, R. I. Jr., Lunch-Nyhan, A., Terry, P., et al. 1988. Pulmonary arteriovenous malformations: Techniques and long-term outcome of embolotherapy. Radiology, 169, 663–9.10.1148/radiology.169.3.3186989CrossRefGoogle ScholarPubMed

White, R. I. Jr., Pollak, J. S., and Wirth, J. A. 1996. Pulmonary arteriovenous malformations: Diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol, 7, 787–804.10.1016/S1051-0443(96)70851-5CrossRefGoogle ScholarPubMed

Willemse, R. B., Mager, J. J., Westermann, C. J., et al. 2000. Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg, 92, 779–84.10.3171/jns.2000.92.5.0779CrossRefGoogle ScholarPubMed

Willinsky, R. A., Lasjaunias, P., Terbrugge, K., et al. 1990. Multiple cerebral arteriovenous malformation: Review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology, 32, 207–10.Google ScholarPubMed

Wilmshurst, P. T., Nightingale, S., Walsh, K. P., et al. 2000. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet, 356, 1648–51.10.1016/S0140-6736(00)03160-3CrossRefGoogle ScholarPubMed

Yeung, M., Khan, K. A., Antecol, D. H., et al. 1995. Transcranial Doppler ultrasonography and transesophageal echocardiography in the investigation of pulmonary arteriovenous malformation in a patient with hereditary haemorrhagic telangiectasia presenting with stroke. Stroke, 26, 1941–4.10.1161/01.STR.26.10.1941CrossRefGoogle Scholar

Zukotynski, K., Chan, R. P., Chow, C. M., et al. 2007. Contrast echocardiography grading predicts pulmonary arteriovenous malformations on CT. Chest, 132, 18–23.10.1378/chest.06-2356CrossRefGoogle ScholarPubMed

Adams, H. P., Subbiah, B., and Bosch, E. P. 1977. Neurologic aspects of hereditary haemorrhagic telangiectasia. Arch Neurol, 34, 101–4.10.1001/archneur.1977.00500140055011CrossRefGoogle Scholar

Albucher, J. F., Carles, P., Giron, P., Guiraud-Chaumeil, B., and Chollet, F. 1996. Accident vasculaire cérébral ischémique au cours de la maladie de Rendu Osler: A propos d’un cas. Rev Neurol (Paris), 152, 283–7.Google Scholar

Barreto, L., Amiel, J. B., Dugard, A., et al. 2013. The Rendu–Osler–Weber disease revealed by a refractory hypoxemia and cerebral severe fat embolism. Case Rep Crit Care, Article 434965.Google Scholar

Begbie, M. E., Wallace, G. M., and Shovlin, C. L. 2003. Hereditary haemorrhagic telangiectasia (Osler–Weber–Rendu syndrome): A view from the 21st century. Postgrad Med J, 79, 18–24.10.1136/pmj.79.927.18CrossRefGoogle ScholarPubMed

Bennesser Alaoui, H., Lehraiki, M., et al. 2015. Bevacizumab: A new success in hereditary hemorrhagic telangiectasia. Rev Med Int, 9, 623–5.Google Scholar

Braverman, I. M., Keh, A., and Jacobson, B. S. 1990. Ultrastructure and three-dimensional organization of the telangiectases of hereditary haemorrhagic telangiectasia. J Invest Dermatol, 95, 422–7.10.1111/1523-1747.ep12555569CrossRefGoogle Scholar

Dingenouts, C. K., Goumans, M. J., and Bakker, W. 2015. Mononuclear cells and vascular repair in HHT. Front Genet, 6, 114.10.3389/fgene.2015.00114CrossRefGoogle ScholarPubMed

Dong, S. L., Reynolds, S. F., and Steiner, I. P. 2001. Brain abscess in patients with hereditary hemorrhagic telangiectasia: Case report and literature review. J Emerg Med, 20, 247–51.10.1016/S0736-4679(00)00315-2CrossRefGoogle ScholarPubMed

Fisher, M. and Zito, J. L. 1983. Focal cerebral ischemia distal to a cerebral aneurysm in hereditary hemorrhagic telangiectasia. Stroke, 14, 419–21.10.1161/01.STR.14.3.419CrossRefGoogle ScholarPubMed

Fressinaud, C., Pasco-Papon, A., Brugeilles-Baguelin, H., and Emile, J. 2000. Complication inhabituelle de la maladie de Rendu–Osler–Weber: Le syndrome bulbaire paramédian. Rev Neurol (Paris), 156, 388–91.Google Scholar

Fuchizaki, U., Miyamori, H., Kitagawa, S., et al. 2003. Hereditary haemorrhagic telangiectasia (Rendu–Osler–Weber disease). Lancet, 362, 1490–4.10.1016/S0140-6736(03)14696-XCrossRefGoogle ScholarPubMed

Fulbright, R., Chaloupka, J., Putman, C., et al. 1998. MR of hereditary haemorrhagic telangiectasia: Prevalence and spectrum of cerebrovascular malformations. Am J Neuroradiol, 19, 477–84.Google ScholarPubMed

Garcia-Monaco, R., Taylor, W., Rodesch, G., et al. 1995. Pial arteriovenous fistula in children as presenting manifestation of Rendu–Osler–Weber disease. Neuroradiology, 37, 60–4.10.1007/BF00588522CrossRefGoogle ScholarPubMed

Garcia-Tsao, G., Korzenik, J. R., Young, L., et al. 2000. Liver disease in patients with hereditary haemorrhagic telangiectasia. N Engl J Med, 343, 931–6.10.1056/NEJM200009283431305CrossRefGoogle Scholar

Garg, N., Khunger, M., Gupta, A. et al. 2014. Optimal management of hereditary hemorrhagic telangiectasia. J Blood Med, 5, 191–206.Google ScholarPubMed

Guttmacher, A. E., Marchuk, D. A., and White, R. I. 1995. Hereditary hemorrhagic telangiectasia. N Engl J Med, 333, 918–24.10.1056/NEJM199510053331407CrossRefGoogle ScholarPubMed

Haitjema, T., Westerman, C. J. J., Overtoom, T. T. C., et al. 1996. Hereditary haemorrhagic telangiectasia (Osler–Weber–Rendu disease). New insights in pathogenesis complications and treatment. Arch Intern Med, 156, 714–9.10.1001/archinte.1996.00440070028004CrossRefGoogle Scholar

Hewes, R. C., Auster, M., and White, R. I. 1985. Cerebral embolism: First manifestation of pulmonary arteriovenous malformation in patients with hereditary haemorrhagic telangiectasia. Cardiovasc Intervent Radiol, 8, 151–5.10.1007/BF02552883CrossRefGoogle Scholar

Hodgson, C. H., Burchell, H. B., Good, G. A., and Clagett, O. T. 1959. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous fistula. Survey of a large family. N Engl J Med, 261, 625–36.10.1056/NEJM195909242611301CrossRefGoogle ScholarPubMed

Kato, Y., Maruyama, H., Uchino, A., and Tanahashi, N. 2014. Late-onset portosystemic encephalopathy in a patient with Rendu–Osler–Weber disease. Intern Med, 53, 2653–4.10.2169/internalmedicine.53.3140CrossRefGoogle Scholar

Kimura, K., Minematsu, K., and Nakajima, M. 2004. Isolated pulmonary arteriovenous fistula without Rendu–Osler–Weber disease as a cause of cryptogenic stroke. J Neurol Neurosurg Psychiatry, 75, 311–3.Google ScholarPubMed

Kjeldsen, A. and Kjeldsen, J. 2000. Gastrointestinal bleeding in patients with hereditary haemorrhagic telangiectasia. Am J Gastroenterol, 95, 415–8.10.1111/j.1572-0241.2000.01792.xCrossRefGoogle Scholar

Krings, T., Ozanne, A., Chng, S. M., et al. 2005. Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age. Review of 50 consecutive patients aged 1 day–60 years. Neuroradiology, 47, 711–20.10.1007/s00234-005-1390-8CrossRefGoogle ScholarPubMed

Lesca, G., Plauchu, H., Coulet, F., et al. 2004. Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary haemorrhagic telangiectasia in France. Hum Mutat, 23, 289–99.10.1002/humu.20017CrossRefGoogle Scholar

Lesca, G., Olivieri, C. H., Burnichon, N., et al. 2007. Genotype–phenotype correlations in hereditary hemorrhagic telangiectasia: Data from the French–Italian HHT network. Genet Med, 9, 14–22.10.1097/GIM.0b013e31802d8373CrossRefGoogle ScholarPubMed

Love, B. B., Biller, J., Landas, S. K., and Hoover, W. W. 1992. Diagnosis of pulmonary arteriovenous malformation by ultrafast chest computed tomography in Rendu–Osler–Weber syndrome with cerebral ischemia: A case report. Angiology, 43, 552–8.10.1177/000331979204300612CrossRefGoogle ScholarPubMed

Maher, C. O., Piepgras, D. G., Brown, R. D. et al. 2001. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke, 32, 877–82.10.1161/01.STR.32.4.877CrossRefGoogle ScholarPubMed

Marchuk, D. A., Srinivasan, S., Squire, T. L., and Zawitowski, J. S. 2003. Vascular morphogenesis: Tales of two syndromes. Hum Mol Genet, 12, R97–112.10.1093/hmg/ddg103CrossRefGoogle ScholarPubMed

Matsubara, S., Mandzia, J. L., ter Brugge, K., Willinsky, R. A., and Faughnan, N. E. 2000. Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary haemorrhagic telangiectasia. Am J Neuroradiol, 21, 1016–20.Google Scholar

McAllister, K. A., Grogg, K. M., Gallione, C. J., et al. 1994. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for haemorrhagic telangiectasia type 1. Nat Genet, 8, 345–51.10.1038/ng1294-345CrossRefGoogle Scholar

McDonald, J., Wooderchak-Donahue, W., VanSant Webb, C., et al. 2015. Hereditary hemorrhagic telangiectasia: Genetics and molecular diagnosis in a new era. Front Genet, 6, 1.10.3389/fgene.2015.00001CrossRefGoogle Scholar

Neau, J. P., Boissonnot, L., Boutaud, P., et al. 1987. Manifestations neurologiques de la maladie de Rendu–Osler–Weber. A propos de 4 observations. Rev Méd Interne, 8, 75–8.CrossRefGoogle Scholar

Nishida, T., Faughan, M.E., Grings, T., et al. 2012. Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: Gene–phenotype correlations. Am J Med Genetic, 11, 2829–34.Google Scholar

Ondra, S. L., Troupp, H., George, E. D., and Schwab, K. 1990. The natural history of symptomatic arteriovenous malformations of the brain: A 24-year follow-up assessment. J Neurosurg, 73, 331–7.10.3171/jns.1990.73.3.0387CrossRefGoogle ScholarPubMed

Osler, W. 1901. On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. John Hopkins Hospital Bulletin, 12, 333–7.Google Scholar

Peery, W. H. 1987. Clinical spectrum of hereditary haemorrhagic telangiectasia (Osler–Weber–Rendu disease). Am J Med, 82, 989–97.10.1016/0002-9343(87)90162-8CrossRefGoogle ScholarPubMed

Plauchu, H., de Chadarévian, J. P., Bideau, A., and Robert, J. M. 1989. Age-related clinical profile of hereditary haemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet, 32, 291–7.CrossRefGoogle Scholar

Porteous, M. E. M., Burn, J., and Proctor, S. J. 1992. Hereditary haemorrhagic telangiectasia: A clinical analysis. J Med Genet, 29, 527–30.10.1136/jmg.29.8.527CrossRefGoogle ScholarPubMed

Putman, C. M., Chaloupka, J. C., Fulbright, R. K., et al. 1996. Exceptional multiplicity of cerebral arteriovenous malformations associated with hereditary haemorrhagic telangiectasia (Osler–Weber–Rendu syndrome). Am J Neuroradiol, 17, 1733–42.Google ScholarPubMed

Rendu, H. 1896. Epistaxis répétées chez un sujet porteur de petits angiomes cutanés et muqueux. Bulletin des Membres de la Société de Médecine Hospitaliére de Paris, 13, 731–3.Google Scholar

Roman, G., Fisher, M., Perl, D. P., and Poser, C. M. 1978. Neurological manifestations of hereditary haemorrhagic telangiectasia (Rendu–Osler–Weber disease): Report of two cases and review of the literature. Ann Neurol, 4, 130–44.10.1002/ana.410040207CrossRefGoogle ScholarPubMed

Shovlin, C. L., Guttmacher, A. E., Buscarini, E., et al. 2000. Diagnostic criteria for hereditary haemorrhagic telangiectasia (Rendu–Osler–Weber disease). Am J Med Genet, 91, 66–7.10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P3.0.CO;2-P>CrossRefGoogle Scholar

Sisel, R. J., Parker, B. M., and Bahl, O. P. 1970. Cerebral symptoms in pulmonary arteriovenous fistula. A result of paradoxical emboli? Circulation, 46, 123–8.Google Scholar

Stapf, C., Mast, H., Sciacca, R. R., et al. 2006. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology, 66, 1350–5.10.1212/01.wnl.0000210524.68507.87CrossRefGoogle ScholarPubMed

Thompson, R. L., Cattaneo, S. M., and Barnes, J. 1977. Recurrent brain abscess: Manifestation of pulmonary arteriovenous fistula and hereditary haemorrhagic telangiectasia. Chest, 72, 654–5.10.1378/chest.72.5.654CrossRefGoogle Scholar

Velthuis, S., Buscarini, E., van Gent, M. W., et al. 2013. Grade of pulmonary right to left shunt on contrast echocardiography and cerebral complications: A striking association. Chest, 144, 542–8.10.1378/chest.12-1599CrossRefGoogle ScholarPubMed

White, R. I., Lynch-Nyhan, A., Terry, P., et al. 1988. Pulmonary arteriovenous malformations: Techniques and long-term outcome of embolotherapy. Radiology, 169, 663–9.10.1148/radiology.169.3.3186989CrossRefGoogle ScholarPubMed

White, R. I. Jr., Pollak, J. S., and Whurth, J. A. 1996. Pulmonary arteriovenous malformations diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol, 7, 787–804.10.1016/S1051-0443(96)70851-5CrossRefGoogle ScholarPubMed

Wilkins, E. G., O’Fearghail, M., and Carroll, J. D. 1983. Recurrent cerebral abscess in hereditary haemorrhagic telangiectasia. J Neurol Neurosurg Psychiatry, 46, 963–5.10.1136/jnnp.46.10.963-aCrossRefGoogle Scholar

Willemse, R. B., Mager, J. J., Westermann, C. J., et al. 2000. Bleeding risk of cerebrovascular malformations in hereditary haemorrhagic telangiectasia. J Neurosurg, 92, 779–84.10.3171/jns.2000.92.5.0779CrossRefGoogle Scholar

Yoshida, Y., Weon, Y. C., Sachet, M., et al. 2004. Posterior cranial fossa single-hole arteriovenous fistulae in children: 14 consecutive cases. Neuroradiology, 46, 474–81.10.1007/s00234-004-1176-4CrossRefGoogle ScholarPubMed

Adachi, T., Kobayashi, S., Yamashita, K., Shimote, K., & Tsunematsu, T. (1992). Nippon Ronen Igakkai Zasshi 29, 591–595.10.3143/geriatrics.29.591CrossRefGoogle Scholar

Auer, D. P., Putz, B., Gossl, C., et al. (2001). Radiology 218, 443–451.10.1148/radiology.218.2.r01fe24443CrossRefGoogle Scholar

Aylward, E. D., Roberts-Willie, J. V., Barta, P. E., et al. (1994). Am J Psychiatry 5, 687–693.Google Scholar

Baudrimont, M., Dubas, F., Joutel, A., Tournier-Lasserve, E., & Bousser, M. G. (1993). Stroke 24, 122–125.10.1161/01.STR.24.1.122CrossRefGoogle ScholarPubMed

Bhatia, K. & Marsden, C. (1994). Brain 117, 859–876.10.1093/brain/117.4.859CrossRefGoogle Scholar

Bianchi, S., Scali, O., Dotti, M. T., et al. (2005). Hum Genet 118, 546.Google Scholar

Biousse, V., Chabriat, H., Amarenco, P., & Bousser, M. G. (1995). Lancet 346, 767.10.1016/S0140-6736(95)91525-7CrossRefGoogle Scholar

Bousser, M. G. & Tournier-Lasserve, E. (1994). Stroke 25, 704–707.10.1161/01.STR.25.3.704CrossRefGoogle Scholar

Capone, C., Cognat, E., Ghezali, L., et al. (2016). Ann Neurol 79, 387–403.10.1002/ana.24573CrossRefGoogle Scholar

Chabriat, H. & Bousser, M. G. (2000). Rev Prat 50, 585–588.Google Scholar

Chabriat, H., Tournier-Lasserve, E., Vahedi, K., et al. (1995b). Neurology 45, 1086–1091.10.1212/WNL.45.6.1086CrossRefGoogle Scholar

Chabriat, H., Vahedi, K., Iba-Zizen, M. T., et al. (1995b). Lancet 346, 934–939.10.1016/S0140-6736(95)91557-5CrossRefGoogle Scholar

Chabriat, H., Joutel, A., Vahedi, K., et al. (1996). J Mal Vasc 21, 277–282.Google Scholar

Chabriat, H., Joutel, A., Vahedi, K., et al. (1997). Rev Neurol (Paris) 153, 376–385.Google Scholar

Chabriat, H., Levy, C., Taillia, H., et al. (1998). Neurology 51, 452–457.10.1212/WNL.51.2.452CrossRefGoogle Scholar

Chabriat, H., Mrissa, R., Levy, C., et al. (1999). Stroke 30, 457–459.10.1161/01.STR.30.2.457CrossRefGoogle Scholar

Chabriat, H., Joutel, A., Dichgans, M., Tournier-Lasserve, E., & Bousser, M. G. (2009). Lancet Neurol 8, 643–653.10.1016/S1474-4422(09)70127-9CrossRefGoogle Scholar

Chabriat, H., Herve, D., Duering, M., et al. (2016). Stroke 47, 4-11.10.1161/STROKEAHA.115.010696CrossRefGoogle Scholar

Colmant, H. (1980). Zbl Allgemein Pathol Bd 124, 163.Google Scholar

Coto, E., Menendez, M., Navarro, R., Garcia-Castro, M., & Alvarez, V. (2006). Eur J Neurol 13, 628–31.10.1111/j.1468-1331.2006.01337.xCrossRefGoogle Scholar

Cumurciuc, R., Guichard, J. P., Reizine, D., et al. (2006). Eur J Neurol 13, 187–190.10.1111/j.1468-1331.2006.01113.xCrossRefGoogle Scholar

Davous, P. & Bequet, D. (1995). Rev Neurol (Paris) 151, 634–9.Google Scholar

Davous, P. & Fallet-Bianco, C. (1991). Rev Neurol (Paris) 147, 376–384.Google Scholar

Desmond, D. W., Moroney, J. T., Lynch, T., et al. (1999). Stroke 30, 1230–1233.10.1161/01.STR.30.6.1230CrossRefGoogle Scholar

Dichgans, M. & Petersen, D. (1997). Lancet 349, 776–777.10.1016/S0140-6736(05)60202-4CrossRefGoogle Scholar

Dichgans, M. & Gasser, T. (1998). Deutsche Med Wochenschr 123, 979–981.10.1055/s-2007-1024107CrossRefGoogle Scholar

Dichgans, M., Herzog, J., & Gasser, T. (2001). Neurology 57, 1714–1717.10.1212/WNL.57.9.1714CrossRefGoogle Scholar

Dichgans, M., Ludwig, H., Muller-Hocker, J., Messerschmidt, A., & Gasser, T. (2000). Eur J Hum Genet 8, 280–285.10.1038/sj.ejhg.5200460CrossRefGoogle Scholar

Dichgans, M., Markus, H. S., Salloway, S., et al. (2008). Lancet Neurol 7, 310–318.10.1016/S1474-4422(08)70046-2CrossRefGoogle Scholar

Dichgans, M., Mayer, M., Uttner, I., et al. (1998). Ann Neurol 44, 731–739.10.1002/ana.410440506CrossRefGoogle Scholar

Dotti, M. T., De Stefano, N., Bianchi, S., et al. (2004). Arch Neurol 61, 942–945.10.1001/archneur.61.6.942CrossRefGoogle Scholar

Duering, M., Gesierich, B., Seiler, S., et al. (2014). Neurology 82, 1946-1950.10.1212/WNL.0000000000000475CrossRefGoogle Scholar

Formichi, P., Parnetti, L., Radi, E., et al. (2010). Int J of Alzheimer’s Dis 2010.Google Scholar

Furby, A., Vahedi, K., Force, M., et al. (1998). J Neurol 245, 734–740.CrossRefGoogle Scholar

Gray, F., Robert, F., Labrecque, R., et al. (1994). Neuropathol Appl Neurobiol 20, 22–30.10.1111/j.1365-2990.1994.tb00953.xCrossRefGoogle Scholar

Guey, S., Mawet, J., Herve, D., et al. (2015). Cephalalgia 36, 1038–1047.Google Scholar

Gutierrez-Molina, M., Caminero Rodriguez, A., Martinez Garcia, C., et al. (1994). Acta Neuropathol 87, 98–105.CrossRefGoogle Scholar

Holtmannspotter, M., Peters, N., Opherk, C., et al. (2005). Stroke 36, 2559–2565.10.1161/01.STR.0000189696.70989.a4CrossRefGoogle Scholar

Joutel, A., Chabriat, H., Vahedi, K., et al. (2000). Neurology 54, 1874–1875.10.1212/WNL.54.9.1874CrossRefGoogle Scholar

Joutel, A., Corpechot, C., Ducros, A., et al. (1996). Nature 383, 707–710.10.1038/383707a0CrossRefGoogle Scholar

Joutel, A., Corpechot, C., Ducros, A., et al. (1997a). Ann N Y Acad Sci 826, 213–217.10.1111/j.1749-6632.1997.tb48472.xCrossRefGoogle Scholar

Joutel, A., Favrole, P., Labauge, P., et al. (2001). Lancet 358, 2049–2051.10.1016/S0140-6736(01)07142-2CrossRefGoogle Scholar

Joutel, A., Vahedi, K., Corpechot, C., et al. (1997b). Lancet 350, 1511–1515.10.1016/S0140-6736(97)08083-5CrossRefGoogle Scholar

Jouvent, E., Reyes, S., De Guio, F., & Chabriat, H. (2015). J Alzheimer’s Dis 47, 413–419.10.3233/JAD-150083CrossRefGoogle Scholar

Kilarski, L. L., Rutten-Jacobs, L. C., Bevan, S., et al. (2015). PloS One 10, e0136352.10.1371/journal.pone.0136352CrossRefGoogle Scholar

Lammie, G. A., Rakshi, J., Rossor, M. N., Harding, A. E., & Scaravilli, F. (1995). Clin Neuropathol 14, 201–206.Google Scholar

Lesnik Oberstein, S. A., van Duinen, S. G., van den Boom, R., et al. (2003). Acta Neuropathol 106, 107–111.10.1007/s00401-003-0701-6CrossRefGoogle Scholar

Low, W. C., Junna, M., Borjesson-Hanson, A., et al. (2007). Brain 130, 357–367.10.1093/brain/awl360CrossRefGoogle Scholar

Lucas, C., Pasquier, F., Leys, D., Ruchoux, M. M., & Pruvo, J. P. (1995). Rev Med Int 16, 290–292.10.1016/0248-8663(96)80711-9CrossRefGoogle Scholar

Monet-Lepretre, M., Haddad, I., Baron-Menguy, C., et al. (2013). Brain 136, 1830–1845.10.1093/brain/awt092CrossRefGoogle Scholar

Monet, M., Domenga, V., Lemaire, B., et al. (2007). Hum Mol Genet 16, 982–992.10.1093/hmg/ddm042CrossRefGoogle Scholar

Narayan, S. K., Gorman, G., Kalaria, R. N., Ford, G. A., & Chinnery, P. F. (2012). Neurology 78, 1025–1027.10.1212/WNL.0b013e31824d586cCrossRefGoogle Scholar

Opherk, C., Duering, M., Peters, N., et al. (2009). Hum Mol Genet 18, 2761–2767.10.1093/hmg/ddp211CrossRefGoogle Scholar

Opherk, C., Peters, N., Herzog, J., Luedtke, R., & Dichgans, M. (2004). Brain 127, 2533–2539.10.1093/brain/awh282CrossRefGoogle Scholar

Peters, N., Opherk, C., Bergmann, T., et al. (2005). Arch Neurol 62, 1091–1094.10.1001/archneur.62.7.1091CrossRefGoogle Scholar

Pullicino, P., Ostow, P., Miller, L., Snyder, W., & Muschauer, F. (1995). Ann Neurol 37, 460–466.10.1002/ana.410370408CrossRefGoogle Scholar

Ragno, M., Tournier-Lasserve, E., Fiori, M. G., et al. (1995). Ann Neurol 38, 231–236.10.1002/ana.410380216CrossRefGoogle Scholar

Razvi, S. S., Davidson, R., Bone, I., & Muir, K. W. (2005). J Neurol Neurosurg Psychiatry 76, 739–741.10.1136/jnnp.2004.051847CrossRefGoogle Scholar

Requena, I., Indakoetxea, B., Lema, C., et al. (1999). Revista Neurol 29, 1048–1051.CrossRefGoogle Scholar

Reyes, S., Viswanathan, A., Godin, O., et al. (2009). Neurology 72, 905–910.10.1212/01.wnl.0000344166.03470.f8CrossRefGoogle Scholar

Rinnoci, V., Nannucci, S., Valenti, R., et al. (2013). J Neurol Sci 330, 45–51.10.1016/j.jns.2013.04.002CrossRefGoogle Scholar

Ruchoux, M. M. & Maurage, C. A. (1997). J Neuropathol Exp Neurol 56, 947–964.10.1097/00005072-199709000-00001CrossRefGoogle Scholar

Ruchoux, M. M., Chabriat, H., Bousser, M. G., Baudrimont, M., & Tournier-Lasserve, E. (1994). Stroke 25, 2291–2292.10.1161/01.STR.25.11.2291CrossRefGoogle Scholar

Ruchoux, M. M., Guerouaou, D., Vandenhaute, B., et al. (1995). Acta Neuropathol 89, 500–512.10.1007/BF00571504CrossRefGoogle Scholar

Sabbadini, G., Francia, A., Calandriello, L., et al. (1995). Brain 118, 207–215.10.1093/brain/118.1.207CrossRefGoogle Scholar

Salvi, F., Michelucci, R., Plasmati, R., et al. (1992). Ital J Neurol Sci 13, 135–140.10.1007/BF02226962CrossRefGoogle Scholar

Schon, F., Martin, R. J., Prevett, M., et al. (2003). J Neurol Neurosurg Psychiatry 74, 249–252.10.1136/jnnp.74.2.249CrossRefGoogle Scholar

Schroder, J. M., Sellhaus, B., & Jorg, J. (1995). Acta Neuropathol 89, 116–121.10.1007/BF00296354CrossRefGoogle Scholar

Singhal, S., Bevan, S., Barrick, T., Rich, P., & Markus, H. S. (2004). Brain 127, 2031–2038.10.1093/brain/awh223CrossRefGoogle Scholar

Tikka, S., Mykkanen, K., Ruchoux, M. M., et al. (2009). Brain 132, 933–939.10.1093/brain/awn364CrossRefGoogle Scholar

Tournier-Lasserve, E., Iba-Zizen, M. T., Romero, N., & Bousser, M. G. (1991). Stroke 22, 1297–1302.10.1161/01.STR.22.10.1297CrossRefGoogle Scholar

Tournier-Lasserve, E., Joutel, A., Melki, J., et al. (1993). Nat Genet 3, 256–259.10.1038/ng0393-256CrossRefGoogle Scholar

Tuominen, S., Juvonen, V., Amberla, K., et al. (2001). Stroke 32, 1767–1774.10.1161/01.STR.32.8.1767CrossRefGoogle Scholar

Unlu, M., de Lange, R. P., de Silva, R., Kalaria, R., & St Clair, D. (2000). Neurosci Lett 282, 149–152.10.1016/S0304-3940(00)00875-2CrossRefGoogle Scholar

Vahedi, K., Chabriat, H., Levy, C., et al. (2004). Arch Neurol 61, 1237–1240.10.1001/archneur.61.8.1237CrossRefGoogle Scholar

van Den Boom, R., Lesnik Oberstein, S. A., van Duinen, S. G., et al. (2002). Radiology 224, 791–796.10.1148/radiol.2243011123CrossRefGoogle Scholar

Verin, M., Rolland, Y., Landgraf, F., et al. (1995). J Neurol Neurosurg Psychiatry 59, 579–585.10.1136/jnnp.59.6.579CrossRefGoogle Scholar

Viswanathan, A., Guichard, J. P., Gschwendtner, A., et al. (2006). Brain 129, 2375–2383.10.1093/brain/awl177CrossRefGoogle Scholar

Viswanathan, A., Gschwendtner, A., Guichard, J. P., et al. (2007). Neurology 69, 172–179.10.1212/01.wnl.0000265221.05610.70CrossRefGoogle Scholar

Viswanathan, A., Godin, O., Jouvent, E., et al. (2010). Neurobiol Aging 31, 1629–1636.10.1016/j.neurobiolaging.2008.09.001CrossRefGoogle Scholar

Wang, T., Sharma, S. D., Fox, N., et al. (2000). J Neurol Neurosurg Psychiatry 69, 652–654.10.1136/jnnp.69.5.652CrossRefGoogle Scholar

Weller, M., Petersen, D., Dichgans, J., & Klockgethe, T. (1996). Neurology 46, 844.Google Scholar

Yamamoto, Y., Ihara, M., Tham, C., et al. (2009). Stroke 40, 2004–2011.10.1161/STROKEAHA.108.528299CrossRefGoogle Scholar

Yao, M., Herve, D., Jouvent, E., et al. (2014). Cerebrovasc Dis 37, 155–163.10.1159/000356982CrossRefGoogle Scholar

Zhang, W. W., Ma, K. C., Andersen, O., et al. (1994). Acta Neuropathol 87, 317–324.10.1007/BF00296749CrossRefGoogle Scholar

Zicari, E., Tassi, R., Stromillo, M. L., et al. (2008). Stroke 39, 2155–2157.10.1161/STROKEAHA.107.506311CrossRefGoogle Scholar

Arima, K., Yanagawa, S., Ito, N., et al. (2003). Cerebral arterial pathology of CADASIL and CARASIL (Maeda syndrome). Neuropathology, 23, 327–34.10.1046/j.1440-1789.2003.00519.xCrossRefGoogle ScholarPubMed

Arisato, T., Hokezu, Y., Suehara, M., et al. (1993). Juvenile Binswanger-type encephalopathy with alopecia and spondylosis deformans: A case report. Clinical Neurology (Rinsho Shinkeigaku), 33, 400–4. (in Japanese with English abstract)Google ScholarPubMed

Bayrakli, F., Balaban, H., Gurelik, M., et al. (2014). Mutation in the HTRA1 gene in a patient with degenerated spine as a component of CARASIL syndrome. Turkish Neurosurgery, 24, 67–9.Google Scholar

Beaufort, N., Scharrer, E., Kremmer, E. et al. (2014). Cerebral small vessel disease-related protease HTRA1 processes latent TGF-β binding protein 1 and facilitates TGF-β signaling. Proceedings of the National Academy of Sciences of the United States of America, 111, 16496–501.Google ScholarPubMed

Bianchi, S., Di Palma, C., Gallus, G. N., et al. (2014). Two novel HTRA1 mutations in a European CARASIL patient. Neurology, 82, 898–900.10.1212/WNL.0000000000000202CrossRefGoogle Scholar

Bowler, J. V. & Hachinski, V. (1994). Progress in the genetics of cerebrovascular disease: inherited subcortical arteriopathies. Stroke, 25, 1696–8.10.1161/01.STR.25.8.1696CrossRefGoogle ScholarPubMed

Cai, B., Zeng, J., Lin, Y., et al. (2015). A frameshift mutation in HTRA1 expands CARASIL syndrome and peripheral small arterial disease to the Chinese population. Neurological Sciences, 36, 1387–91.10.1007/s10072-015-2121-5CrossRefGoogle ScholarPubMed

Caplan, L. R. & Gomes, J. A. (2010). Binswanger disease: An update. Journal of the Neurological Sciences, 299, 9–10.10.1016/j.jns.2010.08.041CrossRefGoogle ScholarPubMed

Caplan, L. R. & Schoene, W. C. (1978). Clinical features of subcortical arteriosclerotic encephalopathy (Binswanger disease). Neurology, 28, 1206–15.10.1212/WNL.28.12.1206CrossRefGoogle ScholarPubMed

Chen, Y., He, Z., Meng, S., et al. (2013). A novel mutation of the high-temperature requirement A serine protease 1 (HTRA1) gene in a Chinese family with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). The Journal of International Medical Research, 41, 1445–55.10.1177/0300060513480926CrossRefGoogle Scholar

Clausen, T., Southan, C., & Ehrmann, M. (2002). The HTRA family of proteases: Implications for protein composition and cell fate. Molecular Cell, 10, 443–55.10.1016/S1097-2765(02)00658-5CrossRefGoogle ScholarPubMed

Dewan, A., Lie, M., Hartman, S., et al. (2006). HTRA1 promotor polymorphism in wet age-related macular degeneration. Science, 314, 989–92.10.1126/science.1133807CrossRefGoogle Scholar

Di Donato, I., Bianchi, S., Gallus, G. N., et al. (2017). Heterozygous mutations of HTRA1 gene in patients with familial cerebral small vessel disease. CNS Neuroscience & Therapeutics, 23, 759–65.10.1111/cns.12722CrossRefGoogle Scholar

Filliat, G., Mirsaidi, A., Tiaden, A. N., et al. (2017). Role of HTRA1 in bone formation and regeneration: In vitro and in vivo evaluation. PLoS One, 12, e0181600.10.1371/journal.pone.0181600CrossRefGoogle ScholarPubMed

Filley, C. M. (2012). The Behavioral Neurology of White Matter, 2nd edn. Oxford: Oxford University Press.10.1093/med/9780199743261.001.0001CrossRefGoogle ScholarPubMed

Fujita, Y., Lin, J. X., Tkahashi, R., et al. (2008). Cilostazol alleviates cerebral small-vessel pathlogy and white-matter lesions in stroke-prone spontaneously hypertensive rats. Brain Research, 1203, 170–6.10.1016/j.brainres.2008.01.103CrossRefGoogle Scholar

Fukutake, T. (2006). Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): A severe model of cerebral small vessel diseases frequently seen in Japan. Neurological Medicine (Shinkei Naika), 65, 460–7. (in Japanese)Google Scholar

Fukutake, T. (2010). Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencepahlopathy (CARASIL): Presenting with cerebral small-vessel disease, alopecia and spinal degeneration. Neurological Medicine (Shinkei Naika), 72, 391–9. (in Japanese)Google Scholar

Fukutake, T. (2011). Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy: From discovery to gene identification. Journal of Stroke and Cerebrovascular Diseases, 20, 85–93.10.1016/j.jstrokecerebrovasdis.2010.11.008CrossRefGoogle ScholarPubMed

Fukutake, T. & Hirayama, K. (1995). Familial young-adult-onset arteriosclerotic leukoencephalopathy with alopecia and lumbago without arterial hypertension (clinical review). European Neurology, 35, 69–79.10.1159/000117096CrossRefGoogle Scholar

Fukutake, T., Hattori, T., Kita, K., et al. (1985). Familial juvenile encephalopathy (Binswanger type) with alopecia and lumbago: A syndrome. Clinical Neurology (Rinsho Shinkeigaku), 25, 949–55. (in Japanese with English abstract)Google ScholarPubMed

Fukutake, T., Shimoe, Y., & Hattori, T. (2000) Differences in MRI lesion patterns of two hereditary vascular leukoencephalopathy: CADASIL and CARASIL. Journal of Stroke and Cerebrovascular Disease, 9 (Suppl 1), 263–4.Google Scholar

Hara, K., Shiga, A., Fukutake, T., et al. (2009). Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. New England Journal of Medicine, 360, 1729–39.10.1056/NEJMoa0801560CrossRefGoogle ScholarPubMed

Hashida, N., Ito, S., Hasegawa, T., et al. (2009). Case of optic neuritis associated with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). Nippon Ganka Gakkai Zasshi, 113, 505–12. (in Japanese with English abstract)Google ScholarPubMed

Inui, S., Fukuzato, Y., Nakajima, T., et al. (2002). Androgen-inducible TGF-beta1 from balding dermal papilla cells inhibits epithelial cell growth: A cue to understand paradoxical effect of androgen on human hair growth. FASEB Journal, 16, 1967–9.10.1096/fj.02-0043fjeCrossRefGoogle Scholar

Ito, S., Takao, M., Fukutake, T., et al. 2016. Histopathologic analysis of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): Neuropathology and general pathology in three genetically-confirmed cases. J Neuropathol Exp Neurol Sep 15 [Epub ahead of print].10.1093/jnen/nlw078CrossRefGoogle Scholar

Iwasaki, Y., Kato, T., Sone, M., et al. (1997). Young adult onset Binswanger-type leukoencephalopathy with alopecia and spondylosis deformans. Report of a female case. Neurological Medicine (Shinkei Naika), 47, 593–600. (in Japanese with English abstract)Google Scholar

Joutel, A., Corpechot, C., Ducros, A., et al. (1996). NOTCH3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature, 383, 707–10.10.1038/383707a0CrossRefGoogle ScholarPubMed

Kast, J., Hanecker, P., Beaufort, N., et al. (2014). Sequestration of latent TGF-β binding protein 1 into CADASIL-related NOTCH3-ECD deposits. Acta Neuropathologica Communications, 2, 96.10.1186/s40478-014-0096-8CrossRefGoogle ScholarPubMed

Khaleeli, Z., Jaunmuktane, Z., Beaufort, N., et al. (2015). A novel HTRA1 exon 2 mutation causes loss of protease activity in a Pakistani CARASIL patient. Journal of Neurology, 262, 1369–72.10.1007/s00415-015-7769-5CrossRefGoogle Scholar

Kuriyama, N., Mizuno, T., Kita, M., et al. (2014). TGF-beta1 is associated with the progression of intracranial deep white matter lesions: A pilot study with 5 years of magnetic resonance imaging follow-up. Neurological Research, 36, 47–52.10.1179/1743132813Y.0000000256CrossRefGoogle ScholarPubMed

Lan, T. H., Huang, X. Q., & Tan, H. M. (2013). Vascular fibrosis in atherosclerosis. Cardiovascular Pathology, 22, 401–7.10.1016/j.carpath.2013.01.003CrossRefGoogle ScholarPubMed

Maeda, S., Nakayama, H., Isaka, K., et al. (1976). Familial unusual encephalopathy of Binswanger’s type without hypertension. Folia Psychiatrica et Neurologica Japonica, 30, 165–77.Google ScholarPubMed

Mendioroz, M., Fernández-Cadenas, I., Del Rio-Espinola, A., et al. (2010). A missense HTRA1 mutation expands CARASIL syndrome to the Caucasian population. Neurology, 75, 2033–5.10.1212/WNL.0b013e3181ff96acCrossRefGoogle Scholar

Menedez Cordeiro, I., Nzwalo, H., Sá, F., et al. (2015). Shifting the CARASIL paradigm: Report of non-Asian family and literature review. Stroke, 46, 1110–2.Google Scholar

Nemoto, S. (1966). Einige Beitrage zur Encephalitis subcorticalis chronic progressive (Binswanger). In Festschrift zum Rucktritt von Prof. Toshimi Ishibashi. Sendai: Tohoku University, pp. 51–67. (in Japanese with German abstract)Google Scholar

Nishimoto, Y., Shibata, M., Nihonmatsu, M., et al. (2011). A novel mutation in the HTRA1 gene causes CARASIL without alopecia. Neurology, 76, 1353–5.10.1212/WNL.0b013e318215281dCrossRefGoogle ScholarPubMed

Nozaki, H., Nishizawa, M., & Onodera, O. (2014). Features of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke, 45, 3447–53.10.1161/STROKEAHA.114.004236CrossRefGoogle ScholarPubMed

Nozaki, H., Kato, T.., Nihonmatsu, M., et al. (2016). Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL. Neurology, 86, 1964–74.10.1212/WNL.0000000000002694CrossRefGoogle Scholar

Nozaki, Y., Sekine, Y., Fukutake, T., et al. (2015). Characteristic features and progression of abnormalities on MRI for CARASIL. Neurology, 85, 459–63.10.1212/WNL.0000000000001803CrossRefGoogle ScholarPubMed

Oide, T., Nakayama, H., Yanagawa, S., et al. (2008). Extensive loss of arterial medial muscle cells and mural extracellular matrix in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). Neuropathology, 28, 132–42.10.1111/j.1440-1789.2007.00864.xCrossRefGoogle ScholarPubMed

Oka, C., Tsujimoto, R., Kajikawa, M., et al. (2004). HTRA1 serine protease inhibits signaling mediated by TGF beta family proteins. Development, 131, 1041–53.10.1242/dev.00999CrossRefGoogle Scholar

Okeda, R., Murayama, S., Sawabe, M., et al. (2004). Pathology of the cerebral artery in Binswanger’s disease in the aged: Observation by serial sections and morphometry of the cerebral arteries. Neuropathology, 24, 21–9.10.1111/j.1440-1789.2003.00534.xCrossRefGoogle ScholarPubMed

Onodera, O., Nozaki, H., & Fukutake, T. (2010). CARASIL. GeneReview, Apr 27 [updated Sep 11, 2014].Google Scholar

Shiga, A., Nozaki, H., Yokoseki, A., et al. (2011). Cerebral small-vessel disease protein HTRA1 controls the amount of TGF-β1 via cleavage of proTGF-β1. Human Molecular Genetics, 20, 1800–10.10.1093/hmg/ddr063CrossRefGoogle ScholarPubMed

Shin, H., Yoo, H.G., Inui, S., et al. (2013). Induction of transforming growth factor-beta 1 by androgen is mediated by reactive oxygen species in hair follicle dermal papilla cells. BMB Reports, 46, 460–4.10.5483/BMBRep.2013.46.9.228CrossRefGoogle ScholarPubMed

Shirata, A. & Yamane, K. (2004). A case of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. The Journal of Movement Disorder and Disability, 14, 71–4. (in Japanese with English abstract)Google Scholar

Shizuma, N., Ikeguchi, K., Hiranouchi, N., et al. (1993). A female case of young-adult-onset subcortical encephalopathy with diffuse baldness and spondylosis. Neurological Medicine (Shinkei Naika), 39, 406–10. (in Japanese with English abstract)Google Scholar

Takeshita, T., Nakagawa, S., Ttsumi, R., et al. (2014). Cilostazol attenuates ischemia-perfusion-induced blood–brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling. Molecular and Cellular Neurosciences, 60, 1–9.10.1016/j.mcn.2014.01.006CrossRefGoogle Scholar

Tang, S. Y. & Alliston, T. (2013). Regulation of postnatal bone homeostasis by TGFβ. BoneKey Reports, 2, 255.10.1038/bonekey.2012.255CrossRefGoogle ScholarPubMed

Tiaden, A. N. & Richards, P. J. (2013). The emerging roles of HTRA1 in musculoskeletal disease. The American Journal of Pathology, 182(5), 1482–8.10.1016/j.ajpath.2013.02.003CrossRefGoogle ScholarPubMed

Tikka, S., Baumann, M., Siitonen, M., et al. (2014). CADASIL and CARASIL. Brain Pathology, 24, 525–44.10.1111/bpa.12181CrossRefGoogle ScholarPubMed

Tsuchiya, A., Yano, M., Tocharus, J., et al. (2005). Expression of mouse HTRA1 serine protease in normal bone and cartilage and its upregulation in joint cartilage damaged by experimental arthritis. Bone, 37, 323–36.10.1016/j.bone.2005.03.015CrossRefGoogle ScholarPubMed

Urano, T., Narusawa, K, Kobayashi, S., et al. (2010). Association of HTRA1 promotor polymorphism with spinal disc degeneration in Japanese women. Journal of Bone and Mineral Metabolism, 28, 220–6.10.1007/s00774-009-0124-0CrossRefGoogle Scholar

van der Knaap, M. S. & Valk, J. (2005). Magnetic Resonance of Myelination and Myelin Disorders, 3rd edn. Berlin: Springer, pp. 541–51.10.1007/3-540-27660-2CrossRefGoogle Scholar

Verdura, E., Herve, D., Scharrer, E., et al. (2015). Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease. Brain, 138, 2347–58.10.1093/brain/awv155CrossRefGoogle ScholarPubMed

Wang, X. L., Li, C. F., Guo, H. W., et al. (2012). A novel mutation in the HTRA1gene identified in Chinese CARASIL pedigree. CNS Neuroscience and Therapeutics, 18, 867–9.10.1111/j.1755-5949.2012.00373.xCrossRefGoogle ScholarPubMed

Yamamura, T., Nishimura, M., Shirabe, T., et al. (1987). Subcortical vascular encephalopathy in a normotensive, young adult with premature baldness and spondylitis deformans. A clinicopathological study and review of the literature. Journal of the Neurological Science, 78, 175–88.10.1016/0022-510X(87)90059-1CrossRefGoogle Scholar

Yanagawa, S., Ito, N., Arima, K., et al. (2002). Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Neurology, 58, 817–20.10.1212/WNL.58.5.817CrossRefGoogle ScholarPubMed

Zheng, D. M., Xu, F. F., Gao, Y., et al. (2009). A Chinese pedigree of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): Clinical and radiological features. Journal of Clinical Neuroscience, 16, 847–9.10.1016/j.jocn.2008.08.031CrossRefGoogle ScholarPubMed

Adams, R., Aaslid, R., el Gammal, T., Nichols, F., & McKie, V. (1988a) Detection of cerebral vasculopathy in sickle cell disease using transcranial Doppler ultrasonography and magnetic resonance imaging. Case report. Stroke, 19, 518–520.10.1161/01.STR.19.4.518CrossRefGoogle Scholar

Adams, R. J., Nichols, F. T., McKie, V., et al. (1988b) Cerebral infarction in sickle cell anemia: Mechanism based on CT and MRI. Neurology, 38, 1012.10.1212/WNL.38.7.1012CrossRefGoogle ScholarPubMed

Adams, R. J., Nichols, F. T., Stephens, S., et al. (1988c) Transcranial Doppler: The influence of age and hematocrit in normal children. Journal of Cardiovascular Ultrasonography, 7, 201–205.Google Scholar

Adams, R. J., Nichols, F. T., McKie, V. C, et al. (1989) Transcranial Doppler: Influence of hematocrit in children with sickle cell anemia without stroke. Journal of Cardiovascular Technology, 8, 97–101.Google Scholar

Adams, R. J., Nichols, F. T. I., Aaslid, R., et al. (1990) Cerebral vessel stenosis in sickle cell disease: Criteria for detection by transcranial Doppler. Journal of Pediatric Hematology/Oncology, 12, 277–282.10.1097/00043426-199023000-00005CrossRefGoogle ScholarPubMed

Adams, R., McKie, V., Nichols, F., et al. (1992a) The use of transcranial ultrasonography to predict stroke in sickle cell disease. New England Journal of Medicine, 326, 605–610.10.1056/NEJM199202273260905CrossRefGoogle ScholarPubMed

Adams, R. J., Nichols, F. T., Figueroa, R., McKie, V., & Lott, T. (1992b) Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke, 23, 1073–1077.10.1161/01.STR.23.8.1073CrossRefGoogle ScholarPubMed

Adams, R. J., McKie, V. C., Hsu, L., et al. (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. New England Journal of Medicine, 339, 5–11.10.1056/NEJM199807023390102CrossRefGoogle ScholarPubMed

Adams, R. J., Brambilla, D. J., Granger, S., et al. (2004) Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood, 103, 3689–3694.10.1182/blood-2003-08-2733CrossRefGoogle ScholarPubMed

Adams, R. J., Brambilla, D., & Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators (2005) Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. New England Journal of Medicine, 353, 2769–2778.Google ScholarPubMed

Alkan, O., Kizilkilic, E., Kizilkilic, O., et al. (2010) Cranial involvement in sickle cell disease. Eur J Radiol, 76, 151–156.10.1016/j.ejrad.2009.05.032CrossRefGoogle ScholarPubMed

Atweh, G. F., DeSimone, J., Saunthararajah, Y., et al. (2003) Hemoglobinopathies. Hematology, 1, 14–39.10.1182/asheducation-2003.1.14CrossRefGoogle Scholar

Aygun, B., Padmanabhan, S., Paley, C., & Chandrasekaran, V. (2002) Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion, 42, 37–43.10.1046/j.1537-2995.2002.00007.xCrossRefGoogle ScholarPubMed

Bernaudin, F., Verlhac, S., Freard, F., et al. (2000) Multicenter prospective study of children with sickle cell disease: Radiographic and psychometric correlation. Journal of Child Neurology, 15, 333–343.10.1177/088307380001500510CrossRefGoogle ScholarPubMed

Bernaudin, F., Verlhac, S., Arnaud, C., et al. (2011) Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood, 117, 1130–1140; quiz 1436.10.1182/blood-2010-06-293514CrossRefGoogle Scholar

Bernaudin, F., Verlhac, S., Arnaud, C., et al. (2015) Chronic, acute anemia and eICA stenosis are independent risk factors for silent cerebral infarcts in sickle cell anemia. Blood, 125, 1653–1661.10.1182/blood-2014-09-599852CrossRefGoogle ScholarPubMed

Borgna Pignatti, C., Carnelli, V., Caruso, V., et al. (1998) Thromboembolic events in beta thalassemia major: An Italian multicenter study. Acta Haematologica, 99, 76–79.10.1159/000040814CrossRefGoogle ScholarPubMed

Centers for Disease Control and Prevention (2012) Children with sickle cell disease had significantly higher medical costs than those without sickle cell disease. Atlanta, GA: Centers for Disease Control and Prevention.Google Scholar

Clarke, G. M. & Higgins, T. N. (2000) Laboratory investigation of hemoglobinopathies and thalassemias: Review and update. Clinical Chemistry, 46, 1284–1290.10.1093/clinchem/46.8.1284CrossRefGoogle Scholar

Connes, P., Verlhac, S., & Bernaudin, F. (2013) Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia. British Journal of Haematology, 161, 484–498.10.1111/bjh.12300CrossRefGoogle ScholarPubMed

DeBaun, M. R., Gordon, M., McKinstry, R. C., et al. (2014) Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. New England Journal of Medicine, 371, 699–710.10.1056/NEJMoa1401731CrossRefGoogle ScholarPubMed

Dobson, S. R., Holden, K. R., Nietert, P. J., et al. (2002) Moyamoya syndrome in childhood sickle cell disease: A predictive factor for recurrent cerebrovascular events. Blood, 99, 3144–3150.10.1182/blood.V99.9.3144CrossRefGoogle ScholarPubMed

Dowling, M. M., Quinn, C. T., Plumb, P., et al. (2012) Acute silent cerebral ischemia and infarction during acute anemia in children with and without sickle cell disease. Blood, 120, 3891–3897.10.1182/blood-2012-01-406314CrossRefGoogle ScholarPubMed

England, J., Rowan, R., Dawson, D., et al. (1988) Guidelines for haemoglobinopathy screening. Clinical & Laboratory Haematology, 10, 87–94.10.1111/j.1365-2257.1988.tb01156.xCrossRefGoogle Scholar

Feldenzer, J., Mears, J. G., Burns, A. L., Natta, C., & Bank, A. (1979) Heterogeneity of DNA fragments associated with the sickle-globin gene. Journal of Clinical Investigation, 64, 751–755.10.1172/JCI109519CrossRefGoogle ScholarPubMed

Fisher, T. C. (2000) PEG-coated red blood cells: Simplifying blood transfusion in the new millennium? Immunohematology, 16, 37–48.10.21307/immunohematology-2019-576CrossRefGoogle ScholarPubMed

Gebreyohanns, M. & Adams, R. J. (2004) Sickle cell disease: Primary stroke prevention. CNS Spectrums, 9, 445–449.Google ScholarPubMed

Gluckman, E. (2013) Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease. Hematology, 2013, 370–376.10.1182/asheducation-2013.1.370CrossRefGoogle ScholarPubMed

Goldstein, L. B., Bushnell, C. D., Adams, R. J., et al. (2011) Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 42, 517–584.10.1161/STR.0b013e3181fcb238CrossRefGoogle ScholarPubMed

Griessenauer, C. J., Lebensburger, J. D., Chua, M. H., et al. (2015) Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease. J Neurosurg Pediatr, 16, 64–73.10.3171/2014.12.PEDS14522CrossRefGoogle ScholarPubMed

Herrick, J. B. (1910) Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Archives of Internal Medicine, VI, 517–521.10.1001/archinte.1910.00050330050003CrossRefGoogle Scholar

Hulbert, M. L., Scothorn, D. J., Panepinto, J. A., et al. (2006) Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: A retrospective cohort study of 137 children with sickle cell anemia. The Journal of Pediatrics, 149, 710–712.10.1016/j.jpeds.2006.06.037CrossRefGoogle ScholarPubMed

Hulbert, M. L., McKinstry, R. C., Lacey, J. L., et al. (2011) Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood, 117, 772–779.10.1182/blood-2010-01-261123CrossRefGoogle ScholarPubMed

Jeffries, B., Lipper, M., & Kishore, P. (1980) Major intracerebral arterial involvement in sickle cell disease. Surgical Neurology, 14, 291–295.Google ScholarPubMed

Jordan, L. C., Casella, J. F., & DeBaun, M. R. (2012) Prospects for primary stroke prevention in children with sickle cell anaemia. British Journal of Haematology, 157, 14–25.10.1111/j.1365-2141.2011.09005.xCrossRefGoogle ScholarPubMed

Kan, Y. W. & Dozy, A. M. (1980) Evolution of the hemoglobin S and C genes in world populations. Science, 209, 388–391.10.1126/science.7384810CrossRefGoogle Scholar

Kennedy, B. C., McDowell, M. M., Yang, P. H., et al. (2014) Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: A comprehensive review of reported cases. Neurosurg Focus, 36, E12.10.3171/2013.10.FOCUS13405CrossRefGoogle ScholarPubMed

Kernan, W. N., Ovbiagele, B., Black, H. R., et al. (2014) Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 45, 2160–2236.10.1161/STR.0000000000000024CrossRefGoogle ScholarPubMed

Kotb, M. M., Tantawi, W. H., Elsayed, A. A., Damanhouri, G. A., & Malibary, H. M. (2006) Brain MRI and CT findings in sickle cell disease patients from western Saudi Arabia. Neurosciences (Riyadh), 11, 28–36.Google ScholarPubMed

Kwiatkowski, J. L., Zimmerman, R. A., Pollock, A. N., et al. (2009a) Silent infarcts in young children with sickle cell disease. British Journal of Haematology, 146, 300–305.10.1111/j.1365-2141.2009.07753.xCrossRefGoogle Scholar

Kwiatkowski, J. L., Zimmerman, R. A., Pollock, A. N., et al. (2009b) Silent infarcts in young children with sickle cell disease. British Journal of Haematology, 146, 300–305.10.1111/j.1365-2141.2009.07753.xCrossRefGoogle Scholar

Merkel, K., Ginsberg, P., Parker, J., & Post, M. (1978) Cerebrovascular disease in sickle cell anemia: A clinical, pathological and radiological correlation. Stroke, 9, 45–52.10.1161/01.STR.9.1.45CrossRefGoogle ScholarPubMed

Miller, S. T., Macklin, E. A., Pegelow, C. H, et al. (2001) Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: A report from the Cooperative Study of Sickle Cell Disease. Journal of Pediatrics, 139, 385–390.10.1067/mpd.2001.117580CrossRefGoogle ScholarPubMed

Moritani, T., Numaguchi, Y., Lemer, N. B., et al. (2004) Sickle cell cerebrovascular disease: Usual and unusual findings on MR imaging and MR angiography. Clinical Imaging, 28, 173–186.10.1016/S0899-7071(03)00121-9CrossRefGoogle ScholarPubMed

Neel, J. V. (1949) The inheritance of sickle cell anemia. Science, 110, 64–66.10.1126/science.110.2846.64CrossRefGoogle ScholarPubMed

Nemtsas, P., Arnaoutoglou, M., Perifanis, V., Koutsouraki, E., & Orologas, A. (2015) Neurological complications of beta-thalassemia. Annals of Hematology, 94, 1261–1265.10.1007/s00277-015-2378-zCrossRefGoogle ScholarPubMed

Ohene-Frempong, K., Weiner, S. J., Sleeper, L. A., et al. (1998) Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood, 91, 288–294.Google ScholarPubMed

Oyesiku, N. M., Barrow, D. L., Eckman, J. R., Tindall, S. C., & Colohan, A.R. (1991) Intracranial aneurysms in sickle-cell anemia: Clinical features and pathogenesis. Journal of Neurosurgery, 75, 356–363.10.3171/jns.1991.75.3.0356CrossRefGoogle ScholarPubMed